A global plea for treatment

The clock is ticking.

Dr. Julio Montaner, the world-renowned HIV researcher of the B.C. Centre for Excellence in HIV/AIDS, has made an urgent plea to the medical community to recognize that treating patients with highly active antiretroviral therapy (HAART) doubles as an effective tool against the spread of the incurable virus.

Montaner and his team have found that HAART treatment lowers plasma HIV-1 RNA to undetectable levels and cuts the risk of transmission by more than 90 per cent.

Because HAART treatment is readily available in British Columbia and free for patients, the province is one of the few jurisdictions in the world where new HIV diagnoses are declining.

More >>

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below